Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide vs Fluid Expansion in Acute MI with RV Extension
NCT02905760Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of furosemide in right ventricular infarction (RVMI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Improvement in cardiac output at 24 hours. Status: unknown.
02
Drugs
furosemide
03
Conditions
right ventricular infarction (RVMI)
Beyond the preview
Go deeper on NCT02905760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02905760.